Results 301 to 310 of about 825,494 (348)
Clinical case report on the efficacy and safety of savolitinib in elderly patients with non-small cell lung cancer harboring <i>METex14</i> skipping mutations. [PDF]
Transl Cancer ResSun M, Zang D, Zhou H, Chen J.
europepmc +1 more source
Risk and Outcomes of Secondary Cancer Among Lung Cancer Survivors After Definitive Treatment.
JAMA Netw OpenMcMillan MT +11 more
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Therapeutic potentials of curcumin in the treatment of non‐small‐cell lung carcinoma
Phytotherapy Research, 2020Non‐small‐cell lung carcinoma (NSCLC) is one of the most lethal malignancies that include more than 80% of lung cancer cases worldwide. During the past decades, plants and plant‐derived products have attracted great interest in the treatment of various ...
Mahsa Salehi +11 more
semanticscholar +1 more source
Drugs, 1995
Non-small-cell lung cancer (NSCLC) is one of the most common malignancies in developed countries and accounts for millions of deaths worldwide. The incidence of NSCLC correlates with smoking tobacco and is likely to increase in those countries with increasing per capita consumption of tobacco.
K T, Bastin, R, Curley
openaire +2 more sources
Non-small-cell lung cancer (NSCLC) is one of the most common malignancies in developed countries and accounts for millions of deaths worldwide. The incidence of NSCLC correlates with smoking tobacco and is likely to increase in those countries with increasing per capita consumption of tobacco.
K T, Bastin, R, Curley
openaire +2 more sources
Breast Metastasis from Non-Small-Cell Lung Carcinoma
Medical Oncology, 2003Development of metastasis to the breast from lung cancer is very rare and the prognosis for such patients is poor. We present a patient who had metastasis to breast from non-small-cell lung cancer. It is important to distinguish a primary breast cancer from metastasis to the breast, as the therapy offered would be markedly different, with considerably ...
Kannan, Ramar +3 more
openaire +2 more sources
Journal of Clinical Oncology, 2020
PURPOSE The aim of this work is to provide evidence-based recommendations updating the 2017 ASCO guideline on systemic therapy for patients with stage IV non-small-cell lung cancer (NSCLC) without driver alterations.
N. Hanna +22 more
semanticscholar +1 more source
PURPOSE The aim of this work is to provide evidence-based recommendations updating the 2017 ASCO guideline on systemic therapy for patients with stage IV non-small-cell lung cancer (NSCLC) without driver alterations.
N. Hanna +22 more
semanticscholar +1 more source
Molecular Diagnostics in Non-Small Cell Lung Carcinoma
Seminars in Respiratory and Critical Care Medicine, 2020AbstractCurrent clinical practice guidelines recognize EGFR, BRAF, ALK, and ROS1 as essential molecular biomarkers, and a host of other genetic alterations as emerging biomarkers for non-small cell lung carcinoma patients. The available approaches to detecting relevant alterations in these genes are diverse and often complementary.
openaire +2 more sources
Paraneoplastic mononeuritis multiplex in non-small-cell lung carcinoma
Journal of Clinical Neuroscience, 2006A 60-year-old man developed two selective peripheral mononeuropathies of the peroneal and later the radial nerve, shortly after a diagnosis of large-cell lung carcinoma. Nerve conduction studies and electromyography confirmed isolated lesions in both nerves, and in the case of the peroneal nerve lesion, focal conduction block was localised to the level
Annabel C, Martin +2 more
openaire +2 more sources
Non-Small-Cell Carcinoma of the Lung
1991It is estimated that in the United States during 1989, 155000 cases of carcinoma of the lung will occur and that close to 142000 of these patients will die within 1 year from their disease (Silver-Berg and Lubera 1989). At present in the United States, the incidence and death rate from this disease for females has surpassed that for breast cancer in ...
Hassan Aziz +4 more
openaire +1 more source